TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26873055

Group type: EXPERIMENTAL
Intervention: IPV (3-dose primary vaccination)
Number of subjects: 1076

Group type: COMPARATOR
Intervention: OPV (3-dose primary vaccination)
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: IPV (booster vaccination at 18-24 months)
Number of subjects: 1076

Group type: COMPARATOR
Intervention: OPV (booster vaccination at 18-24 months)
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: IPV (overall safety profile)
Number of subjects: 1076
Study: 23412248

Group type: EXPERIMENTAL
Intervention: Reformed lumbar microdiscectomy with curved incision and more preservation of ligamentum flavum
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional lumbar microdiscectomy
Number of subjects: 0
Study: 22934396

Group type: EXPERIMENTAL
Intervention: Acupuncture group (needle-retention at Baihui (GV 20) and Sishencong (EX-HN 1), retained for 8 hours)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Medication group (Nifedipine tablets 20 mg orally in the morning)
Number of subjects: 24
Study: 20182161

Group type: EXPERIMENTAL
Intervention: Internet coping skills training program
Number of subjects: 12

Group type: COMPARATOR
Intervention: Internet education intervention
Number of subjects: 12
Study: 18376092

Group type: EXPERIMENTAL
Intervention: Intermittent methylene blue therapy (Gr I, n=5)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Continuous methylene blue therapy (Gr II, n=6)
Number of subjects: 11
Study: 15753425

Group type: EXPERIMENTAL
Intervention: Anodal DC (1 mA)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Cathodal DC (1 mA)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Sham DC (1 mA)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Anodal DC (2 mA)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Cathodal DC (2 mA)
Number of subjects: 103
Study: 12466165

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005% once daily
Number of subjects: 28

Group type: COMPARATOR
Intervention: Brimonidine tartrate 0.2% twice daily
Number of subjects: 28
Study: 10071993

Group type: EXPERIMENTAL
Intervention: General anesthesia (GA) with fentanyl/propofol/rocuronium
Number of subjects: 60

Group type: COMPARATOR
Intervention: Thoracic epidural anesthesia (TEA) with propofol/rocuronium/epidural thoracic bupivacaine 0.5%
Number of subjects: 60
Study: 7673542

Group type: EXPERIMENTAL
Intervention: Minimal-contact cognitive bibliotherapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 80
Study: 2200931

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 149
Study: 7024868

Group type: EXPERIMENTAL
Intervention: Azatadine maleate (Zadine) 2 mg twice daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Azatadine maleate (Zadine) 1 mg twice daily
Number of subjects: 20
Study: 30784354

Group type: EXPERIMENTAL
Intervention: Baricitinib
Number of subjects: 514
Study: 30040589

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (CBT) for sexual dysfunction
Number of subjects: 69
Study: 28213565

Group type: EXPERIMENTAL
Intervention: Golimumab 50 mg every 4 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 26416942

Group type: EXPERIMENTAL
Intervention: Topical and intraurethral 2% lidocaine gel
Number of subjects: 133

Group type: COMPARATOR
Intervention: Nonanesthetic lubricant (NAL)
Number of subjects: 133
Study: 24211510

Group type: EXPERIMENTAL
Intervention: Clopidogrel (75 mg daily) for 28 days
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study: 22475140

Group type: EXPERIMENTAL
Intervention: Telbivudine (600 mg/d until postpartum week 4)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control (no telbivudine)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Telbivudine
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control
Number of subjects: 220
Study: 19881322

Group type: EXPERIMENTAL
Intervention: Continuous passive motion (CPM) started on the first postoperative day with conventional physical therapy (n=29)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Continuous passive motion (CPM) started on the third postoperative day with conventional physical therapy (n=29)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Conventional physical therapy only (control group, n=28)
Number of subjects: 86
Study: 17760285

Group type: EXPERIMENTAL
Intervention: Local training (visually upright relative to the local module)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Station training (constant orientation relative to the station)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Mixed training (local followed by station orientation)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Egress testing trials (without the tour guide)
Number of subjects: 36
Study: 14990635

Group type: EXPERIMENTAL
Intervention: 17 Gy per two fractions (n = 146)
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: 42 Gy per 15 fractions (n = 145)
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: 50 Gy per 25 fractions (n = 130)
Number of subjects: 421
Study: 11343232

Group type: EXPERIMENTAL
Intervention: Butyl cyanoacrylate injection (group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Band ligation (group B)
Number of subjects: 60
Study: 9128987

Group type: EXPERIMENTAL
Intervention: Aerobic training (walking on a treadmill) for 6 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 16
Study: 7968423

Group type: EXPERIMENTAL
Intervention: Walking with 0.45 kg hand weights (W1)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Walking with 1.36 kg hand weights (W3)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Walking with 2.27 kg hand weights (W5)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Walking with no weights (W0)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Walking with hand weights (W1, W3, W5) during constant heart rate (CHR)
Number of subjects: 19
Study: 3297595

Group type: EXPERIMENTAL
Intervention: verapamil 120 mg three times daily
Number of subjects: 21
Study: 31417680

Group type: EXPERIMENTAL
Intervention: Pelmeg (pegfilgrastim)
Number of subjects: 171
Study: 28292551

Group type: EXPERIMENTAL
Intervention: Continuous paravertebral block at levels T1 and T2 with bupivacaine infusion
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (group B)
Number of subjects: 36
Study: 25731629

Group type: EXPERIMENTAL
Intervention: Vanutide cridificar (ACC-001) + QS-21 adjuvant
Number of subjects: 0

Group type: COMPARATOR
Intervention: QS-21 alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phosphate-buffered saline
Number of subjects: 0
Study: 23299960

Group type: EXPERIMENTAL
Intervention: Nebulised magnesium sulphate (151 mg per dose)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Nebulised magnesium sulphate
Number of subjects: 116
Study: 21110413

Group type: EXPERIMENTAL
Intervention: Motor Relearning Programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bobath approach
Number of subjects: 0
Study: 19586230

Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 526

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 526
Study: 17100370

Group type: EXPERIMENTAL
Intervention: 0.025 mg/d transdermal estradiol
Number of subjects: 108

Group type: COMPARATOR
Intervention: 0.05 mg/d transdermal estradiol
Number of subjects: 108
Study: 15119922

Group type: EXPERIMENTAL
Intervention: Olanzapine (up to 20 mg/day)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 11231440

Group type: EXPERIMENTAL
Intervention: ANP (30 ng/kg/min) infusion before and after ACEi treatment (n = 9)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Coadministration of ANP with acute saline solution load (n = 8)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Acute saline solution loading (n = 8)
Number of subjects: 17
Study: 9566811

Group type: EXPERIMENTAL
Intervention: Physostigmine (maximal tolerated dose)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8176138

Group type: EXPERIMENTAL
Intervention: Geriatric evaluation and management (GEM)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: GEM
Number of subjects: 154
Study: 2500196

Group type: EXPERIMENTAL
Intervention: Inhaling fully humidified air at 43 degrees C for 20 minutes
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Inhaling fully humidified air at 43 degrees C for 30 minutes on three occasions
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Inhaling fully humidified air at 43 degrees C for 20 minutes at the onset of the cold and for 10 minutes on succeeding days
Number of subjects: 171

Group type: COMPARATOR
Intervention: Inhaling fully humidified air at 30 degrees C
Number of subjects: 171
Study: 4400530

Group type: EXPERIMENTAL
Intervention: M & B 17803A (300 mg)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Propranolol (10 and 40 mg)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Propranolol (40 mg)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: M & B 17803A and Propranolol
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: M & B 17803A (small oral doses)
Number of subjects: 4
Study: 31371154

Group type: EXPERIMENTAL
Intervention: Topical haemostatic agents (oxidized cellulose or collagen) + fibrin glue (experimental group with VADs)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Topical haemostatic agents (oxidized cellulose or collagen) (control group)
Number of subjects: 60
Study: 30712955

Group type: EXPERIMENTAL
Intervention: Progressive respiratory muscle training (RMT) with trunk stabilization exercise (TSE)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Trunk stabilization exercise (TSE)
Number of subjects: 33
Study: 28369078

Group type: EXPERIMENTAL
Intervention: Lower meal frequency (B2)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Six smaller meals a day (A6)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Eating only breakfast and lunch (B2)
Number of subjects: 54
Study: 26043724

Group type: EXPERIMENTAL
Intervention: AZD9668 60 mg twice daily (BID)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: AZD9668 60 mg BID
Number of subjects: 36
Study: 23704939

Group type: EXPERIMENTAL
Intervention: 1.5 mg apomorphine
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 20980352

Group type: EXPERIMENTAL
Intervention: Magnetic knee wraps (MKWs) with a static magnetic field (35 mT) for 12 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham magnetic knee wraps
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (MKWs and sham)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Magnetic knee wraps (MKWs)
Number of subjects: 50
Study: 18953498

Group type: EXPERIMENTAL
Intervention: 1.5 gm IV MgSO(4)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Antihypertensive agent (parenteral or oral)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Both IV MgSO(4) and antihypertensive agent
Number of subjects: 127
Study: 17286764

Group type: EXPERIMENTAL
Intervention: ReFacto
Number of subjects: 0

Group type: COMPARATOR
Intervention: Advate
Number of subjects: 0
Study: 15536901

Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) with real-time visualization and registration using 3-D MR images
Number of subjects: 24
Study: 11182730

Group type: EXPERIMENTAL
Intervention: Mini-open repair
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional open surgery (control group)
Number of subjects: 22
Study: 9875839

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 8300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8300
Study: 7818631

Group type: EXPERIMENTAL
Intervention: Antimicrobial treatment
Number of subjects: 1489

Group type: COMPARATOR
Intervention: Untreated residents
Number of subjects: 1489
Study: 3132034

Group type: EXPERIMENTAL
Intervention: Zinc supplement of 50 mg daily for 2 weeks
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no zinc supplement)
Number of subjects: 25
Study: 27609783

Group type: EXPERIMENTAL
Intervention: Online self-help program
Number of subjects: 53

Group type: COMPARATOR
Intervention: Delayed intervention group (control)
Number of subjects: 53
Study: 30817502

Group type: EXPERIMENTAL
Intervention: Computed tomography-guided percutaneous transthoracic needle biopsy (PTNB)
Number of subjects: 141
Study: 28601273

Group type: EXPERIMENTAL
Intervention: Sepsis-3 criteria for sepsis
Number of subjects: 1591

Group type: EXPERIMENTAL
Intervention: Sepsis-3 criteria for septic shock
Number of subjects: 1591

Group type: COMPARATOR
Intervention: Not meeting Sepsis-3 criteria for sepsis
Number of subjects: 1591

Group type: COMPARATOR
Intervention: Not meeting Sepsis-3 criteria for septic shock
Number of subjects: 1591
Study: 26567090

Group type: EXPERIMENTAL
Intervention: Sleep intervention (two-hour group teaching session and four support calls over 2 weeks)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Sleep intervention
Number of subjects: 235

Group type: COMPARATOR
Intervention: Control teaching sessions (instruction on infant safety)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Control teaching sessions
Number of subjects: 235
Study: 22495500

Group type: EXPERIMENTAL
Intervention: Electrical acupoint stimulation (group T)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine nursing (group C1)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Graduated compression stockings (group C2)
Number of subjects: 120
Study: 21610517

Group type: EXPERIMENTAL
Intervention: Static Stretching (SS)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Quiet Sitting (QS)
Number of subjects: 12
Study: 18269927

Group type: EXPERIMENTAL
Intervention: Omalizumab 0.015 mg/kg/IU/mL every 2 weeks for 28 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Omalizumab 0.030 mg/kg/IU/mL every 2 weeks for 28 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Reduced doses of omalizumab (0.0015 or 0.0050 mg/kg/IU/mL every 2 weeks for 18 weeks)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Complete discontinuation of omalizumab therapy
Number of subjects: 40
Study: 16440917

Group type: EXPERIMENTAL
Intervention: School-based intervention
Number of subjects: 205
Study: 12850599

Group type: EXPERIMENTAL
Intervention: Advance provision of emergency contraception (8 oral contraceptive pills containing 0.15 mg of levonorgestrel and 30 microg of ethinyl estradiol) and a 5-minute educational session
Number of subjects: 370

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Advance provision of emergency contraception
Number of subjects: 370
Study: 10428220

Group type: EXPERIMENTAL
Intervention: Spectron prosthesis
Number of subjects: 410

Group type: COMPARATOR
Intervention: Charnley prosthesis
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Both Charnley and Spectron prostheses
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Both systems
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Cemented hip arthroplasty
Number of subjects: 410
Study: 7484285

Group type: EXPERIMENTAL
Intervention: Alendronate 2.5 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Alendronate 5 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study: 2271372

Group type: EXPERIMENTAL
Intervention: Cholestyramine (8 g)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Activated charcoal (8 g)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Water only
Number of subjects: 6
Study: 7427048

Group type: EXPERIMENTAL
Intervention: Sigvaris medium compression below-knee stockings
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sigvaris strong compression below-knee stockings
Number of subjects: 30

Group type: COMPARATOR
Intervention: Eesiness NHS two-way stretch stockings
Number of subjects: 30

Group type: COMPARATOR
Intervention: Compression stockings (general)
Number of subjects: 30
Study: 28190003

Group type: EXPERIMENTAL
Intervention: Proactive engagement with quitline (multisession counselling)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Reactive engagement with quitline (multisession counselling)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Self-help materials only (study 2) proactive engagement
Number of subjects: 100

Group type: COMPARATOR
Intervention: Self-help materials only (study 2) reactive engagement
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Proactive outreach with quitline
Number of subjects: 100

Group type: COMPARATOR
Intervention: Reactive outreach with quitline
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Proactive outreach with self-help
Number of subjects: 100

Group type: COMPARATOR
Intervention: Reactive outreach with self-help
Number of subjects: 100
Study: 27513384

Group type: EXPERIMENTAL
Intervention: High HPV16 viral load
Number of subjects: 1097

Group type: EXPERIMENTAL
Intervention: High HPV18 viral load
Number of subjects: 1097

Group type: COMPARATOR
Intervention: Low HPV16 viral load
Number of subjects: 1097

Group type: COMPARATOR
Intervention: Low HPV18 viral load
Number of subjects: 1097
Study: 24992277

Group type: EXPERIMENTAL
Intervention: LED activation
Number of subjects: 16

Group type: COMPARATOR
Intervention: LED-laser activation (300 mW/cm2)
Number of subjects: 16
Study: 22398668

Group type: EXPERIMENTAL
Intervention: 200 mg cilostazol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Aspirin and clopidogrel
Number of subjects: 60
Study: 20461791

Group type: EXPERIMENTAL
Intervention: 48-hour immobilization in a triangular sling (n = 46)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Normal activity without restrictions (n = 44)
Number of subjects: 90
Study: 18321680

Group type: EXPERIMENTAL
Intervention: Olanzapine for 6 months
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (normal volunteers)
Number of subjects: 16
Study: 16446029

Group type: EXPERIMENTAL
Intervention: Ectopic expression of Su(Fu) in NCI‐H209 cells
Number of subjects: 0
Study: 14585761

Group type: EXPERIMENTAL
Intervention: LIPC‐480 TT genotype with normal levels of physical activity
Number of subjects: 966

Group type: EXPERIMENTAL
Intervention: LIPC‐480 TT genotype with vigorous physical activity
Number of subjects: 966

Group type: COMPARATOR
Intervention: LIPC‐480 CC/CT genotype with normal physical activity (reference group)
Number of subjects: 966
Study: 11056771

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (nodraparin calcium, Fraxiparine) administered according to body weight
Number of subjects: 200

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 200
Study: 8970281

Group type: EXPERIMENTAL
Intervention: Application of heat for 1 min using an infant heel warmer
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (no heat applied)
Number of subjects: 63
Study: 1457788

Group type: EXPERIMENTAL
Intervention: Manganese DPDP (5 mumol/kg, 10 mumol/ml concentration)
Number of subjects: 20
Study: 6373481

Group type: EXPERIMENTAL
Intervention: Optocillin (mezlocillin and oxacillin) 6 gs after clamping the umbilical cord and after 8 and 16 hours
Number of subjects: 100
Study: 31282364

Group type: EXPERIMENTAL
Intervention: Oral semaglutide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Subcutaneous liraglutide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29886442

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided method (UGM)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Landmark method (LM)
Number of subjects: 114
Study: 25900558

Group type: EXPERIMENTAL
Intervention: RADPAD® drape
Number of subjects: 50

Group type: COMPARATOR
Intervention: No RADPAD® drape
Number of subjects: 50
Study: 23928104

Group type: EXPERIMENTAL
Intervention: 20 Hz rTMS at 110% of motor threshold (MT)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS at 110% of motor threshold (MT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 24
Study: 23002259

Group type: EXPERIMENTAL
Intervention: 10 mg, 0.5% hyperbaric bupivacaine with the Whitacre needle oriented laterally
Number of subjects: 0

Group type: COMPARATOR
Intervention: 10 mg, 0.5% hyperbaric bupivacaine with the Whitacre needle oriented cephalad
Number of subjects: 0
Study: 20418792

Group type: EXPERIMENTAL
Intervention: Cartilage palisade tympanoplasty (CPT)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Tympanoplasty with temporalis muscle fascia (FT)
Number of subjects: 123
Study: 18752991

Group type: EXPERIMENTAL
Intervention: 32-channel banana-avg montage
Number of subjects: 100

Group type: COMPARATOR
Intervention: 16-channel double banana montage
Number of subjects: 100
Study: 15676041

Group type: EXPERIMENTAL
Intervention: 500 mg oral artemisinin daily for 5 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Single oral doses of 100/100/250/250/500 mg on each of the first 5 days
Number of subjects: 24
Study: 12066424

Group type: EXPERIMENTAL
Intervention: Adjective-based sentences
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Noun-based materials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Noun-based sentences
Number of subjects: 0
Study: 10359405

Group type: EXPERIMENTAL
Intervention: Budesonide 800 microg plus 400 microg daily for 6 months followed by 400 microg twice daily for 30 months
Number of subjects: 290

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 290
Study: 2127335

Group type: EXPERIMENTAL
Intervention: 10 mg vancomycin administered into the ventricular system during surgery
Number of subjects: 158

Group type: COMPARATOR
Intervention: Current antimicrobial regimen used in the centre
Number of subjects: 158
Study: 6113060

Group type: EXPERIMENTAL
Intervention: systematic desensitization 'in vivo'
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: systematic desensitization 'in imagination'
Number of subjects: 38

Group type: COMPARATOR
Intervention: no treatment control
Number of subjects: 38
Study: 31952627

Group type: EXPERIMENTAL
Intervention: TAU+CBT4CBT
Number of subjects: 83

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 83